K223231 is an FDA 510(k) clearance for the Ti-Largo Cervical Interbody System. This device is classified as a Intervertebral Fusion Device With Bone Graft, Cervical (Class II - Special Controls, product code ODP).
Submitted by Flospine (Boca Raton, US). The FDA issued a Cleared decision on February 24, 2023, 129 days after receiving the submission on October 18, 2022.
This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3080. Intended To Stabilize Cervical Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft..